Delivery Order SPE2DB20D1100-SPE2DB24FA1N8

Award Date 2/8/24
Potential Completion Date 2/9/24
Potential Value $3.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The contract is for the supply of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a specialty pharmaceutical product, with a potential value of $1,344.53 and a completion date of February 27, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to...
The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $3,645.51 and a period of performance through March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued at up to...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $7,049.48 firm fixed price delivery order contract to supply the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that serves as Amerisourcebergen's primary contract vehicle for delivering pharmaceuticals and medical supplies to DLA...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $1,097.08 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract has a completion date of March 1, 2024. AmerisourceBergen Drug Corp is the prime contractor on this contract, which does not have a set-aside designation. The contract is associated with a larger indefinite delivery contract...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, for the supply of the prescription drug WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The $8,904.64 firm fixed-price contract has a completion date of May 22, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $1,097.08 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution company. The contract is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a pharmaceutical product, with a completion date of March 5, 2024. This award is part of a larger single-award indefinite delivery contract (IDC) worth up to $999,999,999.00...
The U.S. government awarded a delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, valued at $1,097.08. This firm fixed price order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, supporting medical treatment programs and facilities operated by the Department of Defense. The order is for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery...
The U.S. government's Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp a delivery order contract worth $12,850.04 for the pharmaceutical product WEGOVY 0.25 MG/0.5 ML PEN 0.5ML. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical supplies to support...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The potential value of this contract is $5,623.10 and the period of performance runs through March 8, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used. This award is under an existing indefinite delivery...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract for the pharmaceutical product WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a potential value of $2,194.16 and a completion date of January 26, 2024. This award does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FA1N8
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the publicly traded Amerisourcebergen Corporation, to provide a specialty pharmaceutical product called WEGOVY 1 MG/0.5 ML PEN 0.5ML. The order, valued at $3,291.24, has a completion date of February 9, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This contract award does not use any set-aside designations.

Generated 5/9/24, 9:20 AM